Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sigilon Therapeutics Inc (SGTX)

Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,501
  • Shares Outstanding, K 2,514
  • Annual Sales, $ 12,940 K
  • Annual Income, $ -43,560 K
  • 60-Month Beta 4.12
  • Price/Sales 4.48
  • Price/Cash Flow N/A
  • Price/Book 2.05
Trade SGTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.95
  • Most Recent Earnings $-2.89 on 08/07/23
  • Next Earnings Date 08/03/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -3.51
  • Growth Rate Est. (year over year) +28,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.61 +9.02%
on 07/28/23
23.78 -5.53%
on 08/07/23
+0.60 (+2.74%)
since 07/10/23
3-Month
3.80 +491.32%
on 06/27/23
28.00 -19.75%
on 06/29/23
+16.07 (+251.24%)
since 05/10/23
52-Week
3.77 +496.02%
on 12/27/22
28.00 -19.75%
on 06/29/23
+12.87 (+134.05%)
since 08/10/22

Most Recent Stories

More News
Why These 3 Large Caps Are Bucking the August Slump

The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.

LLY : 870.35 (-0.90%)
ANET : 339.85 (-1.96%)
GPN : 99.49 (-0.42%)
DICE : 47.55 (+0.06%)
SGTX : 22.47 (-2.56%)
PYPL : 59.24 (-0.79%)
SQ : 65.94 (-1.42%)
EFX : 264.99 (-1.72%)
EVOP : 33.99 (+0.38%)
Lilly Completes Acquisition of Sigilon Therapeutics

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. (NASDAQ: SGTX)....

LLY : 870.35 (-0.90%)
SGTX : 22.47 (-2.56%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, SGTX, CFMS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
SGTX : 22.47 (-2.56%)
CFMS : 2.26 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
AJX : 3.85 (+1.85%)
IMNM : 14.82 (+7.70%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGTX, AMED, FRG, DHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SGTX : 22.47 (-2.56%)
AMED : 97.75 (+0.31%)
FRG : 29.88 (+0.10%)
DHC : 3.39 (+6.60%)
Moore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

AMED : 97.75 (+0.31%)
KLR : 7.24 (-0.14%)
SGTX : 22.47 (-2.56%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates WMC, SGTX, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
PRTK : 2.23 (+1.83%)
Shareholder Alert: Ademi LLP investigates whether Sigilon Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly

/PRNewswire/ -- Ademi LLP is investigating Sigilon (Nasdaq: SGTX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

SGTX : 22.47 (-2.56%)
Lilly to Acquire Sigilon Therapeutics

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) today announced a definitive agreement for Lilly to acquire...

LLY : 870.35 (-0.90%)
SGTX : 22.47 (-2.56%)
Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor

/PRNewswire/ -- Dimension Inx, a biomaterials platform company developing therapeutics that restore tissue and organ function, announced today the appointments...

SGTX : 22.47 (-2.56%)
ATRS : 5.59 (unch)
VCEL : 52.90 (+2.56%)

Business Summary

Sigilon Therapeutics Inc. is a biotechnology company. It seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics(TM) platform. The company's product candidates consist of novel human cells engineered to produce the crucial proteins, enzymes or factors needed by...

See More

Key Turning Points

3rd Resistance Point 24.03
2nd Resistance Point 23.57
1st Resistance Point 23.02
Last Price 22.47
1st Support Level 22.00
2nd Support Level 21.54
3rd Support Level 20.99

See More

52-Week High 28.00
Last Price 22.47
Fibonacci 61.8% 18.74
Fibonacci 50% 15.89
Fibonacci 38.2% 13.03
52-Week Low 3.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar